EVALUATION OF THE INFLUENCE OF BIFIDOBACTERIUM LACTIS AND HINDIBA INULIN ON FEEDING INTOLERANCE AND WEIGHT GAIN IN PREMATURE BABIES

2016-12-30T05-15-21Z
Source: Cukurova Medical Journal
Çiğdem El, Mehmet Satar, Hacer Yapıcıoğlu Yıldızdaş, Ferda Özlü, Hüseyin Selim Asker.
Aims: To evaluate the influence of Bifidobacterium lactis and Hindiba inulin on feeding intolerance and weight gain in premature babies. Methods: Eigthy nine premature babies with the diagnosis of feeding intolerance were enrolled in the study. Study group had Bifidobacterium lactis (5x109 CFU) + Hindiba inulin (900 mg) (Maflor) per oral, while control group did not have any medication for feeding intolerance. Results: B. Lactis ve H. inulin was started at mean 9.9 days and continued for mean 10 days. Time of full enteral feeding and time of starting oral feeding were longer in study group and this was statistically significant (p0.05). When the groups were compared according to weight gain, study group gained more weight and it was statistically significant (p0.05), babies in the study group diagnosed as in Stage 1 and did not worsen. 33.3% of the babies in the control group progressed to Stage 2. Conclusion: Probiotics and prebiotics might have positive effects due to higher weight gain especially >1500 g birth weight infants and not advancing NEC in the study group having B. Lactis and H. inulin.


from Scope via xlomafota13 on Inoreader http://ift.tt/2ikGnBB
via IFTTT